Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Anne Kirstine, Arveschoug"'
Autor:
Peter Frøhlich Staanum, Anders Floor Frellsen, Marie Louise Olesen, Peter Iversen, Anne Kirstine Arveschoug
Publikováno v:
EJNMMI Physics, Vol 8, Iss 1, Pp 1-25 (2021)
Abstract Background Kidney dosimetry after peptide receptor radionuclide therapy using 177Lu-labelled somatostatin analogues is a procedure with multiple steps. We present the SPECT/CT-based implementation at Aarhus University Hospital and evaluate t
Externí odkaz:
https://doaj.org/article/0310ebdbca504a1180a77a2a6d0530af
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2020)
Multiple endocrine neoplasia 1 (MEN1) is a rare genetic syndrome characterized by the manifestation of tumors in endocrine glands most often in the parathyroid gland (PG). Treatment may involve several parathyroidectomies (PTX), especially in young p
Externí odkaz:
https://doaj.org/article/6116ef14b474445286a4b890aa10b15e
Autor:
Anne Kirstine Arveschoug, Anne Charlotte Bekker, Peter Iversen, Henrik Bluhme, Gerda Elisabeth Villadsen, Peter Frøhlich Staanum
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-7 (2020)
Abstract Background In the case of extravasation of radioactive drugs used in peptide-receptor radionuclide therapy of neuroendocrine tumors, or in radionuclide therapy in general, rapid action is important to reduce or avoid complications. The liter
Externí odkaz:
https://doaj.org/article/089bbd5a3f1e420fa30d3e6d72a631e9
Autor:
Gitte Dam, Henning Grønbæk, Anna Sundlöv, Johan Botling, Anders Sundin, Rene Horsleben Petersen, Staffan Welin, Espen-Thiis Evensen, Halfdan Sorbye, Elizaveta Tabaksblat, Anne Kirstine Arveschoug, Jann Mortensen, Andreas Kjaer, Ulrich Knigge, Eva Tiensuu Janson, Seppo W. Langer
Publikováno v:
Acta Oncologica. :1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a9662f7341ab7f6ae7549cf1247d1ba
https://doi.org/10.1080/0284186x.2023.2212411
https://doi.org/10.1080/0284186x.2023.2212411
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-4 (2018)
A case of follicular thyroid cancer with intense focal Methionine uptake on 11C-Methionine PET/CT is reported here. The use of 11C-Methionine PET in differentiated thyroid cancer is currently being investigated as a surrogate tracer compared to the m
Externí odkaz:
https://doaj.org/article/bef25e8bb0694f298f7ddbc66726f70c
Publikováno v:
Jochumsen, M R, Madsen, M A & Arveschoug, A K 2023, ' Skeletal “Superscan” With 11C-Methionine PET/CT in Polycythemia Vera ', Clinical Nuclear Medicine, vol. 48, no. 4, pp. E198-E199 . https://doi.org/10.1097/RLU.0000000000004559
11C-methionine PET/CT for parathyroid adenoma localization on a 60-year-old woman known with polycythemia vera revealed highly methionine-avid red bone marrow, an uptake pattern that has previously been described in hematological disease such as mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e74fde5f626b1ef6f93e04018e160b
https://pure.au.dk/portal/da/publications/skeletal-superscan-with-11cmethionine-petct-in-polycythemia-vera(4c3c7042-5f5f-4896-823d-ba88c945afc4).html
https://pure.au.dk/portal/da/publications/skeletal-superscan-with-11cmethionine-petct-in-polycythemia-vera(4c3c7042-5f5f-4896-823d-ba88c945afc4).html
Autor:
Marie Louise Olesen, Peter Iversen, Peter Frøhlich Staanum, Anne Kirstine Arveschoug, Anders Floor Frellsen
Publikováno v:
EJNMMI Physics, Vol 8, Iss 1, Pp 1-25 (2021)
Staanum, P F, Frellsen, A F, Olesen, M L, Iversen, P & Arveschoug, A K 2021, ' Practical kidney dosimetry in peptide receptor radionuclide therapy using [ 177 Lu]Lu-DOTATOC and [ 177 Lu]Lu-DOTATATE with focus on uncertainty estimates ', EJNMMI physics, vol. 8, 78 . https://doi.org/10.1186/s40658-021-00422-2
Staanum, P F, Frellsen, A F, Olesen, M L, Iversen, P & Arveschoug, A K 2021, ' Practical kidney dosimetry in peptide receptor radionuclide therapy using [ 177 Lu]Lu-DOTATOC and [ 177 Lu]Lu-DOTATATE with focus on uncertainty estimates ', EJNMMI physics, vol. 8, 78 . https://doi.org/10.1186/s40658-021-00422-2
Background Kidney dosimetry after peptide receptor radionuclide therapy using 177Lu-labelled somatostatin analogues is a procedure with multiple steps. We present the SPECT/CT-based implementation at Aarhus University Hospital and evaluate the uncert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dc364630c95388c32a3accbd3d9336c
https://doaj.org/article/0310ebdbca504a1180a77a2a6d0530af
https://doaj.org/article/0310ebdbca504a1180a77a2a6d0530af
Autor:
Tobias Stemann Lau, Lars Bossen, Daniel Guldager Kring Rasmussen, Morten Karsdal, Federica Genovese, Anne Kirstine Arveschoug, Henning Gronbaek, Gitte Dam
Publikováno v:
Lau, T S, Bossen, L, Guldager Kring Rasmussen, D, Karsdal, M, Genovese, F, Arveschoug, A K, Gronbaek, H & Dam, G 2022, ' Association between fibrosis markers and kidney function following peptide receptor radionuclide therapy in patients with neuroendocrine tumours ', Scandinavian Journal of Clinical and Laboratory Investigation, vol. 82, no. 6, pp. 446-453 . https://doi.org/10.1080/00365513.2022.2119598
Peptide receptor radionuclide therapy (PRRT) is a treatment for neuroendocrine tumours (NET). Renal impairment is a known side effect due to kidney fibrosis. We investigated the association between novel specific fibrosis markers and kidney function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5214a62e7f352188401f4d7db253babb
https://pure.au.dk/portal/da/publications/association-between-fibrosis-markers-and-kidney-function-following-peptide-receptor-radionuclide-therapy-in-patients-with-neuroendocrine-tumours(d6072b74-70d1-48f5-a6d9-6f48ec548b5f).html
https://pure.au.dk/portal/da/publications/association-between-fibrosis-markers-and-kidney-function-following-peptide-receptor-radionuclide-therapy-in-patients-with-neuroendocrine-tumours(d6072b74-70d1-48f5-a6d9-6f48ec548b5f).html
Autor:
Henrik Bluhme, Anne Charlotte Bekker, Peter Iversen, Gerda Elisabeth Villadsen, Peter Frøhlich Staanum, Anne Kirstine Arveschoug
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-7 (2020)
Arveschoug, A K, Bekker, A C, Iversen, P, Bluhme, H, Villadsen, G E & Staanum, P F 2020, ' Extravasation of [ 177 Lu]Lu-DOTATOC : case report and discussion ', EJNMMI research, vol. 10, 68 . https://doi.org/10.1186/s13550-020-00658-6
Arveschoug, A K, Bekker, A C, Iversen, P, Bluhme, H, Villadsen, G E & Staanum, P F 2020, ' Extravasation of [ 177 Lu]Lu-DOTATOC : case report and discussion ', EJNMMI research, vol. 10, 68 . https://doi.org/10.1186/s13550-020-00658-6
Background In the case of extravasation of radioactive drugs used in peptide-receptor radionuclide therapy of neuroendocrine tumors, or in radionuclide therapy in general, rapid action is important to reduce or avoid complications. The literature on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3107807124d8e5b91cc5f855472f60b
http://link.springer.com/article/10.1186/s13550-020-00658-6
http://link.springer.com/article/10.1186/s13550-020-00658-6
Publikováno v:
Luong, T V, Iversen, P, Bouchelouche, K & Arveschoug, A K 2020, ' 68Ga–Prostate-Specific Membrane Antigen Uptake in a Pancreatic Neuroendocrine Tumor ', Clinical Nuclear Medicine, vol. 45, no. 5, pp. 379-382 . https://doi.org/10.1097/RLU.0000000000002997
We present a 60-year-old man with known prostate cancer treated with robot-assisted radical prostatectomy. Prostate-specific antigen levels did not decline accordingly, and a second Ga-PSMA PET/CT demonstrated a new focus with high Ga-PSMA uptake in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa5f9000ecf0f734f82b9a5f52eceaba
https://doi.org/10.1097/rlu.0000000000002997
https://doi.org/10.1097/rlu.0000000000002997